Cytokine circuits in CNS homeostasis and disease
- 23 October 2026
- journal article
- review article
- Published by Springer Nature in Nature Immunology
- Vol. 27 (11) , 2204-2214
Abstract
Cytokines are critical regulators of central nervous system (CNS) integrity, acting not only as immune messengers but also as signals that coordinate interactions among glial and neuronal cells, resident macrophages, such as microglia and border-associated macrophages, and infiltrating leukocytes. These circuits establish basal immune tone, shape responses to perturbation, and promote tissue adaptation and recovery. In this Review, we examine selected cytokine pathways across homeostasis, inflammatory or degenerative tissue damage and repair to develop a framework for how cytokine networks preserve, destabilize and restore CNS integrity. We focus on CSF-1, IL-34, TGFβ and IL-33 in homeostasis; IL-1, TNF, GM-CSF and IFNγ in inflammation; type I and II interferons in antiviral and neurodegenerative states; and IL-12 at the interface of innate sensing, adaptive immunity and tissue-protective adaptation. By focusing on instructive modules, we highlight broader organizing principles and how cytokine miscalibration can lead to neurological disease across diverse contexts.Keywords
This publication has 156 references indexed in Scilit:
- Conserved and cell type-specific transcriptional responses to IFN-γ in the ventral midbrainBrain, Behavior, and Immunity, 2023
- Interleukin-1 promotes autoimmune neuroinflammation by suppressing endothelial heme oxygenase-1 at the blood–brain barrierActa Neuropathologica, 2020
- Cell-specific conditional deletion of interleukin-1 (IL-1) ligands and its receptors: a new toolbox to study the role of IL-1 in health and diseaseJournal of Molecular Medicine, 2020
- Biallelic mutations in NRROS cause an early onset lethal microgliopathyActa Neuropathologica, 2020
- Phenotypic impacts of CSF1R deficiencies in humans and model organismsJournal of Leukocyte Biology, 2019
- A Unique Microglia Type Associated with Restricting Development of Alzheimer’s DiseaseCell, 2017
- Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1European Journal of Immunology, 1999
- TGF-β Receptor Type II Deficiency Results in Defects of Yolk Sac Hematopoiesis and VasculogenesisDevelopmental Biology, 1996
- Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor‐immunoglobulin fusion proteinsEuropean Journal of Immunology, 1994
- T cell immunity and interferon-γ secretion during experimental allergic encephalomyelitis in Lewis ratsJournal of Neuroimmunology, 1991